Clinical trial
REDUCE LAP-HF TRIAL II
NCT03088033 · Corvia Medical, Industry · Active, not recruiting
Key facts
| NCT number | NCT03088033 |
|---|---|
| Title | REDUCE LAP-HF TRIAL II |
| Official title | A Study to Evaluate the Corvia Medical, Inc. IASD® System II to Reduce Elevated Left Atrial Pressure in Patients With Heart Failure |
| Lead sponsor | Corvia Medical, Industry |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Device, Other |
| Interventions | IASD System II implant, intra-cardiac echocardiography (ICE), or transesophageal echocardiography (TEE) |
| Enrollment | 608 |
| Start date | Jun 1, 2017 |
| Primary completion | Jul 29, 2021 |
| Completion | Sep 1, 2026 |
| First posted | Mar 23, 2017 |
| Last update posted | Feb 22, 2023 |
| Countries | Australia, Austria, Belgium, Canada, Croatia, Denmark, France, Germany, Italy, Japan, Netherlands, Poland and 3 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: